Zobrazeno 1 - 10
of 70
pro vyhledávání: '"M. Stokke"'
Autor:
Casper N. Bang, Zhibin Li, Ildri M. Stokke, Sverre E. Kjeldsen, Stevo Julius, Darcy A. Hille, Kristian Wachtell, Richard B. Devereux, Peter M. Okin
Publikováno v:
Exploration of Medicine, Vol 3, Iss 2, Pp 149-159 (2022)
Aim: Whether incident left bundle branch block (LBBB) is associated with increased cardiovascular (CV) morbidity and mortality in treated hypertensive patients with left ventricular hypertrophy (LVH) is unknown. Thus, the present study aimed to exami
Externí odkaz:
https://doaj.org/article/4299c038f5a845e8bff5ca7bac58d154
Autor:
Eran S. Zacks, Ildri M. Stokke, Kristian Wachtell, Darcy A. Hille, Aud Høieggen, Sverre E. Kjeldsen, Stevo Julius, Eva Gerdts, Peter M. Okin, Richard B. Devereux
Publikováno v:
Exploration of Medicine, Vol 3, Iss 2, Pp 128-138 (2022)
Aim: The Losartan Intervention For Endpoint reduction in hypertension (LIFE) study showed less new-onset atrial fibrillation (AF) in hypertensive patients receiving losartan- vs. atenolol-based treatment. Because losartan reduces serum uric acid (SUA
Externí odkaz:
https://doaj.org/article/1f7f2e6f0c3045f9afa145edb49c0133
Autor:
Anne C. K. Larstorp, Ildri M. Stokke, Sverre E. Kjeldsen, Michael Hecht Olsen, Peter M. Okin, Richard B. Devereux, Kristian Wachtell
Publikováno v:
Blood Pressure, Vol 28, Iss 5, Pp 317-326 (2019)
Aims: Atrial fibrillation (AF) is associated with increased cardiovascular risk and the incidence increases with age, hypertension and left ventricular hypertrophy (LVH). Reducing in-treatment systolic blood pressure (SBP) prevents new-onset AF but h
Externí odkaz:
https://doaj.org/article/5a7653ed93964fbc8e94d71a4cb3c38e
Autor:
Ildri M. Stokke, Zhi Bin Li, Silvana Cicala, Peter M. Okin, Sverre E. Kjeldsen, Richard B. Devereux, Kristian Wachtell
Publikováno v:
Blood Pressure, Vol 28, Iss 2, Pp 84-92 (2019)
Aims: We aimed to investigate whether left bundle branch block (LBBB) is related to new-onset left ventricle (LV) wall motion abnormalities during treatment in hypertensive patients with electrocardiographic (ECG) defined left ventricular hypertrophy
Externí odkaz:
https://doaj.org/article/e1c1c62d085e4614b780198c2fefc247
Autor:
K Rypdal, A O Melleby, E L Robinson, S Palmero, D Seifert, D Martin, K Andreassen, C P Dahl, I Sjaastad, T Toennessen, M Stokke, S Heymans, G Christensen, S Apte, I G Lunde
Publikováno v:
European Heart Journal. 43
Background/Introduction Cardiac fibrosis is a central pathophysiological process accompanying most cardiac diseases including heart failure, and is a predictor of poor outcomes. The fibrotic process is mediated by activated cardiac fibroblasts (CFBs)
TIME-VARYING SERUM URIC ACID PREDICTS NEW-ONSET ATRIAL FIBRILLATION IN TREATED HYPERTENSIVE PATIENTS
Autor:
Sverre E. Kjeldsen, Eran S. Zachs, Ildri M. Stokke, Kristian Wachtell, Darcy A. Hille, Aud H⊘ieggen, Stevo Julius, Eva Gerdts, Peter M. Okin, Richard B. Devereux
Publikováno v:
Journal of Hypertension. 40:e3
Autor:
Kristina H. Haugaa, Cecilie E. Kiserud, Thor Edvardsen, Ragnhild V. Nome, Hege Sagstuen Haugnes, A W Bjerring, Thomas M. Stokke, Sophie D. Fosså, Sebastian I. Sarvari
Aims Cisplatin-based chemotherapy (CBCT) is essential in the treatment of metastatic testicular cancer (TC) but has been associated with long-term risk of cardiovascular morbidity and mortality. Furthermore, cisplatin can be detected in the body deca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15dc7acb45739211c95ae91c37e66c3f
http://hdl.handle.net/10852/88078
http://hdl.handle.net/10852/88078
Autor:
Kristina H. Haugaa, Thomas M. Stokke, Klaus Murbraech, Thor Edvardsen, A W Bjerring, M Skei, S Leirstein, Sebastian I. Sarvari, M Lihagen, Henrik Brun, Jostein Hallén, H E W Landgraff
Publikováno v:
European Heart Journal - Cardiovascular Imaging. 21
Funding Acknowledgements South-Eastern Norway Regional Health Authority OnBehalf Center for Cardiological Innovation Background Endurance exercise is closely correlated with physical fitness and the development of the athlete’s heart. The impact of
Autor:
Klaus Murbraech, M Skei, Sebastian I. Sarvari, Henrik Brun, Thomas M. Stokke, M Lihagen, S Leirstein, A W Bjerring, Jostein Hallén, H E W Landgraff, Kristina H. Haugaa, Thor Edvardsen
Publikováno v:
European Heart Journal - Cardiovascular Imaging. 21
Funding Acknowledgements South-Eastern Norway Regional Health Authority OnBehalf Center for Cardiological Innovation Background Recent studies have suggested an initial concentric remodelling in the early development of the athlete’s heart in endur
Autor:
Hamza Z. Ansari, Henrik Bruun, Anette Aaeng, S Leirstein, Kristina H. Haugaa, Klaus Murbraech, Hege E W Landgraff, Thor Edvardsen, Thomas M. Stokke, Sebastian I. Sarvari, Jørg Saberniak, A W Bjerring, Jostein Hallén
Publikováno v:
European Journal of Preventive Cardiology. 25:1000-1007
Background Athlete’s heart is a term used to describe the morphological and functional changes in the hearts of athletes. Recent studies suggest that these changes may occur even in preadolescent athletes. This study aims to improve our understandi